Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 139: 233-243, 2019 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-31376447

RESUMO

Smilax china L. is a traditional Chinese medicine mainly used for the treatment of pelvic inflammation. Polysaccharide might be one of the anti-inflammatory components of Smilax china L. Based on this hypothesis, this work aimed at extraction, purification and structural elucidation of Smilax china L. polysaccharides and their preliminary anti-inflammatory effects were also studied. Two polysaccharides named SCLP1 (Smilax china L. polysaccharide 1, 42.1kDa) and SCLP3-2 (Smilax china L. polysaccharide 3-2, 16.8kDa) were for the first time purified from Smilax china L. The structures of SCLP1 and SCLP3-2 were elucidated by chemical and spectral analysis. The results revealed that SCLP1 was a neutral polysaccharide composed of glucose and mannose (54.5:1.0). Its backbone was 1,4­linked α­Glcp interspersed with 1,2­linked α­Glcp and Manp; the branches were 1,6­linked α-Glcp and terminated with α­Glcp. SCLP3-2 was composed of galacturonic acid, arabinose, galactose and rhamnose (23.3:2.1:1.7:1.0) and was a pectin-type polysaccharide with an α­1,4­linked homogalacturonan backbone which was partially methyl-esterified and slightly acetylated. The side chains consisted of α­Rhap, ß­Galp and α­Araf. SCLP1 and SCLP3-2 could inhibit the production of NO, IL-6 and TNF-α in LPS-stimulated RAW264.7 cells via NF-κB and MAPKs (ERK1/2, JNK) pathways, indicating that they possessed a potential anti-inflammatory activity.


Assuntos
Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Polissacarídeos/química , Polissacarídeos/farmacologia , Smilax/química , Animais , Anti-Inflamatórios/isolamento & purificação , Citocinas/metabolismo , Hidrólise , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Espectroscopia de Ressonância Magnética , Camundongos , Estrutura Molecular , Extratos Vegetais/isolamento & purificação , Polissacarídeos/isolamento & purificação , Células RAW 264.7 , Espectroscopia de Infravermelho com Transformada de Fourier
2.
Toxicol Appl Pharmacol ; 289(2): 142-54, 2015 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-26440581

RESUMO

The natural product totarol, a phenolic diterpenoid and a major constituent isolated from the sap of Podocarpus totara, has been reported to have a potent antimicrobial activity. In this study, we determined whether totarol possessed an additional neuroprotective activity in vitro and in vivo. We found that totarol prevented glutamate- and oxygen and glucose deprivation-induced neuronal death in primary rat cerebellar granule neuronal cells and cerebral cortical neurons. Totarol increased Akt and GSK-3ß phosphorylation, Nrf2 and heme oxygenase-1 (HO-1) protein expressions and suppressed oxidative stress by increasing GSH and SOD activities. The PI3K/Akt inhibitor LY294002 prevented totarol neuroprotective effect by suppressing the totarol-induced changes in HO-1 expression and the activities of GSH and SOD. The HO-1 inhibitor ZnPPIX also prevented totarol-increased GSH and SOD activities. In a model of acute cerebral ischemic injury in Sprague-Dawley rats, produced by occlusion of the middle cerebral artery for 2h followed by 22 h or 46 h of reperfusion, totarol significantly reduced infarct volume and improved the neurological deficit. In this model, totarol increased HO-1 expression and the activities of GSH and SOD. These observations suggest that totarol may be a novel activator of the Akt/HO-1 pathway protecting against ischemic stroke through reduction of oxidative stress.


Assuntos
Antioxidantes/farmacologia , Encéfalo/efeitos dos fármacos , Diterpenos/farmacologia , Heme Oxigenase (Desciclizante)/biossíntese , Infarto da Artéria Cerebral Média/prevenção & controle , Neurônios/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Proteínas Proto-Oncogênicas c-akt/metabolismo , Abietanos , Animais , Encéfalo/enzimologia , Encéfalo/patologia , Morte Celular/efeitos dos fármacos , Hipóxia Celular , Células Cultivadas , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Ativação Enzimática , Indução Enzimática , Agonistas de Aminoácidos Excitatórios/toxicidade , Glucose/deficiência , Ácido Glutâmico/toxicidade , Glutationa/metabolismo , Quinase 3 da Glicogênio Sintase/metabolismo , Glicogênio Sintase Quinase 3 beta , Infarto da Artéria Cerebral Média/enzimologia , Infarto da Artéria Cerebral Média/patologia , Masculino , Fator 2 Relacionado a NF-E2/metabolismo , Neurônios/enzimologia , Neurônios/patologia , Estresse Oxidativo/efeitos dos fármacos , Fosforilação , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...